Safety, tolerability and efficacy of linezolid for the treatment of M/XDR-TB: A systematic review and meta-analysis
G Sotgiu, H Anger, R Centis, L D'Ambrsoio… - 2011 - Eur Respiratory Soc
Background: ≥40% of M/XDR-TB cases treated off-label with a linezolid-containing anti-TB
regimen experienced adverse events (AE). Aim: We performed a systematic review/meta-…
regimen experienced adverse events (AE). Aim: We performed a systematic review/meta-…